| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |